Teva Pharmaceutical Indus (TEVA)
20.80
-0.20 -0.95%
NYSE
May 23, 08:58
Delayed 2m
USD
View All Key Stats
TEVA Key Stats
| Income Statement | |
| Revenue (TTM) | 21.82B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -15.80 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -15.79B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 46.36% |
| Profit Margin (Quarterly) | 22.11% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 21.14B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.9700 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.416 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 1.333B |
| Return on Equity (TTM) | Upgrade |
View All TEVA News
TEVA News
-
WireHeadlineTime (ET)
-
Business Wire05/23 08:00
-
MT Newswires05/23 07:25
-
MT Newswires05/22 07:25
-
MT Newswires05/21 07:19
-
SA Breaking News05/18 08:42
-
SA Breaking News05/18 08:21
-
MT Newswires05/18 07:14
-
MT Newswires05/17 07:12
-
SA Breaking News05/16 16:44
-
MT Newswires05/16 10:17
View All Events
TEVA Events
| Date | Type | Description |
|---|---|---|
| 08/03/2018 | Misc | Teva Pharmaceutical Industries Ltd Second Quarter Earnings Conference Call in 2018 |
| 08/03/2018 | Earnings | Teva Pharmaceutical Industries Ltd Second Quarter Earnings Results in 2018 |
| 05/03/2018 08:00 EDT | Misc | Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call in 2018 |
| 05/03/2018 | Earnings | Teva Pharmaceutical Industries Ltd First Quarter Earnings Results in 2018 |
| 02/12/2018 | Misc | Teva Pharmaceutical Industries Ltd Annual Report in 2017 |
| 02/08/2018 08:00 EST | Misc | Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Conference Call in 2017 |
| 02/08/2018 | Earnings | Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Results in 2017 |
| 12/13/2017 08:00 EST | Misc | Teva to Host Conference Call to Discuss Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance at 8:00 a.m. Et on December 14, 2017 |
| 11/27/2017 | Dividends | Amount: 0.085, Declared Date: Oct 31 2017, Pay Date: Dec 12 2017 |
| 11/02/2017 08:00 EDT | Misc | Teva Pharmaceutical Industries Ltd Third Quarter Earnings Conference Call in 2017 |
TEVA Fundamentals
Income Statement View Statement
TEVA Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
TEVA One Page Reports
- One Page Report Download
TEVA Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 20.80 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.tevapharm.com
- Investor Relations URL: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-irhome
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Large Cap/Value
- Next Earnings Release: Aug. 03, 2018
- Last Earnings Release: May. 03, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 27, 2017
- Description: Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
TEVA Excel Add-In Codes
- Name: =YCI("TEVA","name")
- Description: =YCI("TEVA","description")
- Sector: =YCI("TEVA","sector")
- Industry: =YCI("TEVA","industry")
- Est. Current Fiscal Year End: =YCI("TEVA","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other TEVA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- TEVA Tweets Stocktwits
Advertisement
